Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System

Inclusion Criteria: * Patient with claudication or ischemic rest pain(Rutherford Categories 2-4) * The angiogram will need to have been performed confirming superficial femoral artery short segment occlusion(\<5cm first two patients and \<10cm there on) or high grade(\>50%)stenosis * Patient has a signed and dated informed consent * Patient has a resting ABI \<0.9 or an abnormal exercise ABI if resting ABI is normal. Patients with incompressible arteries (ABI \>1.2) must have TBI \<0.8 * Life expectancy greater than one year * The ability to comply with protocol follow up requirements and required testing * Angiographic lesion requirements assessed at time of procedure * Lesion of the superficial femoral artery with a short segment occlusion(\<5cm first two patients and \<10cm there on) or high grade (\>50%) stenosis * Target lesion 1 cm below profunda/superficial femoral artery origin and 3cm above knee joint * Angiographic evidence of a minimum of at least one tibial with continuous artery runoff to the ankle that does not require intervention * Guidewire has successfully traversed lesion and is within the true lumen of the distal vessel, and successful placement of 9 french(Fr) sheath Exclusion Criteria: * Untreated iliac artery in-flow limiting lesion * Significant proximal common femoral or superficial femoral artery disease above or below target lesion * Any previously treated superficial femoral artery lesion * Any previous stenting or surgery in the target vessel * Femoral or popliteal aneurysm * Non-Atherosclerotic disease resulting in occlusion (e.g. embolism, vasculitis,etc) * Serum creatinine \>2.5 mg/dl * Any previously known coagulation disorder, including hypercoagulability * Severe medical co-morbidities or other medical condition (for example untreated coronary heart disease and congestive heart failure, severe chronic obstructive pulmonary disease, metastasis malignance, etc.)